Zarir Udwadia: Difference between revisions

From Bharatpedia, an open encyclopedia
imported>GrahamHardy
(defsort)
 
m (clean up)
Line 1: Line 1:
'''Zarir Udwadia''' (born 1960) is an [[India]]<nowiki/>n [[Pulmonology|pulmonologist]] and researcher.<ref name=":0">{{Cite news|url=https://www.bbc.com/news/world-asia-india-43456442|title=India's 'tuberculosis warrior'|date=2018-03-24|access-date=2019-08-25|language=en-GB}}</ref><ref name="Aug 18">{{Cite web|url=https://timesofindia.indiatimes.com/city/mumbai/no-more-jabs-now-new-pills-to-treat-tb/articleshow/65446792.cms|title=No more jabs, now new pills to treat TB {{!}} Mumbai News - Times of India|last=Aug 18|first=Malathy Iyer {{!}} TNN {{!}} Updated|last2=2018|website=The Times of India|language=en|access-date=2019-08-26|last3=Ist|first3=6:09}}</ref><ref name=":4">{{Cite web|url=https://www.aljazeera.com/indepth/features/2017/05/challenges-treating-drug-resistant-tb-india-170523133035639.html|title=The challenges of treating drug-resistant TB in India|last=Ubaid|first=Mir|website=www.aljazeera.com|access-date=2019-08-26}}</ref> His work on drug resistant [[tuberculosis]] has led to improvements in India's National Tuberculosis Control Programme.<ref name=":0" /><ref name=":5">{{Cite web|url=http://www.tbonline.info/posts/2016/3/26/right-dose-right-chance-indias-battle-drug-resista/|title=TB Online - The right dose, the right chance: India's battle with drug-resistant TB|website=www.tbonline.info|access-date=2019-08-26}}</ref> Udwadia was the only Indian invited by the [[World Health Organization|WHO]] to be part of the TB ‘Guidelines Group’, which formulated the 4th edition of the TB Guidelines, published in 2010.<ref name=":3">{{Cite web|url=https://www.thebetterindia.com/177155/tuberculosis-day-chest-physician-health-india/|title='The Ticking Time Bomb': A Doctor on Whether TB Can Be Eliminated from India|date=2019-04-04|website=The Better India|language=en-US|access-date=2019-08-25}}</ref><ref name=":6">{{Cite web|url=https://www.hindujahospital.com/dr-zarir-f-udwadia/|title=Chest Physician in Mumbai - Dr Zarir F. Udwadia {{!}} P.D. Hinduja Hospital|website=www.hindujahospital.com|access-date=2019-08-25}}</ref><ref name="Aug 18"/> He was also the only doctor to be named among India's best strategists.<ref name=":1">{{Cite web|url=https://economictimes.indiatimes.com/management-leaders/indias-best-strategists-15-dreamers-who-have-translated-their-insight-into-reality/the-big-healer/slideshow/22873998.cms|title=India's best strategists: 15 dreamers who have translated their insight into reality|website=The Economic Times|access-date=2019-08-25}}</ref>
'''Zarir Udwadia''' (born 1960) is an [[India]]<nowiki/>n [[Pulmonology|pulmonologist]] and researcher.<ref name=":0">{{Cite news|url=https://www.bbc.com/news/world-asia-india-43456442|title=India's 'tuberculosis warrior'|date=2018-03-24|access-date=2019-08-25|language=en-GB}}</ref><ref name="Aug 18">{{Cite web|url=https://timesofindia.indiatimes.com/city/mumbai/no-more-jabs-now-new-pills-to-treat-tb/articleshow/65446792.cms|title=No more jabs, now new pills to treat TB {{!}} Mumbai News - Times of India|last=Aug 18|first=Malathy Iyer {{!}} TNN {{!}} Updated|last2=2018|website=The Times of India|language=en|access-date=2019-08-26|last3=Ist|first3=6:09}}</ref><ref name=":4">{{Cite web|url=https://www.aljazeera.com/indepth/features/2017/05/challenges-treating-drug-resistant-tb-india-170523133035639.html|title=The challenges of treating drug-resistant TB in India|last=Ubaid|first=Mir|website=www.aljazeera.com|access-date=2019-08-26}}</ref> His work on drug resistant [[tuberculosis]] has led to improvements in India's National Tuberculosis Control Programme.<ref name=":0" /><ref name=":5">{{Cite web|url=http://www.tbonline.info/posts/2016/3/26/right-dose-right-chance-indias-battle-drug-resista/|title=TB Online - The right dose, the right chance: India's battle with drug-resistant TB|website=www.tbonline.info|access-date=2019-08-26}}</ref> Udwadia was the only Indian invited by the [[World Health Organization|WHO]] to be part of the TB ‘Guidelines Group’, which formulated the 4th edition of the TB Guidelines, published in 2010.<ref name="Aug 18"/><ref name=":3">{{Cite web|url=https://www.thebetterindia.com/177155/tuberculosis-day-chest-physician-health-india/|title='The Ticking Time Bomb': A Doctor on Whether TB Can Be Eliminated from India|date=2019-04-04|website=The Better India|language=en-US|access-date=2019-08-25}}</ref><ref name=":6">{{Cite web|url=https://www.hindujahospital.com/dr-zarir-f-udwadia/|title=Chest Physician in Mumbai - Dr Zarir F. Udwadia {{!}} P.D. Hinduja Hospital|website=www.hindujahospital.com|access-date=2019-08-25}}</ref> He was also the only doctor to be named among India's best strategists.<ref name=":1">{{Cite web|url=https://economictimes.indiatimes.com/management-leaders/indias-best-strategists-15-dreamers-who-have-translated-their-insight-into-reality/the-big-healer/slideshow/22873998.cms|title=India's best strategists: 15 dreamers who have translated their insight into reality|website=The Economic Times|access-date=2019-08-25}}</ref>


== Professional life ==
== Professional life ==
Udwadia is a graduate of the [[Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals|Grant Medical College]], Mumbai.<ref name=":6" /> He spent five years training in the UK at various centres, including [[Royal Brompton Hospital|Brompton Hospital]], London.<ref name=":6" /><ref name=":5" /> He practices at the [[P.D. Hinduja National Hospital and Medical Research Centre]] and the [[Breach Candy Hospital]], in Mumbai.<ref name=":6" /><ref>{{Cite web|url=https://www.tedxgateway.com/portfolio/zarir-udwadia/|title=Dr.Zarir Udwadia|website=TEDxGateway - India's Largest Ideas Platform (Mumbai, India)|language=en-US|access-date=2019-08-26}}</ref><ref name=":7">{{Cite web|url=https://www.hindustantimes.com/health/scepticism-shrouds-india-s-tuberculosis-target/story-bcyM89SKSxBhtHXxNL9O2L.html|title=Scepticism shrouds India's tuberculosis target|date=2017-12-11|website=Hindustan Times|language=en|access-date=2019-08-26}}</ref> Approximately 8,000 patients pass through his OPD annually.<ref>{{Cite web|url=https://longitudeprize.org/people/dr-zarir-f-udwadia|title=Dr Zarir F Udwadia {{!}} Longitude Prize|website=longitudeprize.org|access-date=2019-08-26}}</ref><ref>{{Cite web|url=https://everylifecounts.ndtv.com/1-indian-dies-tuberculosis-every-minute-no-one-immune-says-expert-15867|title=1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert|last=Taneja|first=Richa|date=2017-08-01|website=Everylifecounts.NDTV.com|language=en-US|access-date=2019-08-26}}</ref> Udwadia established a Chest Medicine Department at the Hinduja Hospital in 1992, and the city’s first Sleep Laboratory in 1994.<ref name=":6" /> He serves on the editorial board of [[Thorax (journal)|Thorax]], a respiratory medicine journal,<ref>{{Cite web|url=https://thorax.bmj.com/pages/editorial-board/|title=Editorial Board|website=Thorax|language=en|access-date=2019-08-25}}</ref> and has authored over 140 publications.<ref name=":3" />  
Udwadia is a graduate of the [[Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals|Grant Medical College]], Mumbai.<ref name=":6" /> He spent five years training in the UK at various centres, including [[Royal Brompton Hospital|Brompton Hospital]], London.<ref name=":5" /><ref name=":6" /> He practices at the [[P.D. Hinduja National Hospital and Medical Research Centre]] and the [[Breach Candy Hospital]], in Mumbai.<ref name=":6" /><ref>{{Cite web|url=https://www.tedxgateway.com/portfolio/zarir-udwadia/|title=Dr.Zarir Udwadia|website=TEDxGateway - India's Largest Ideas Platform (Mumbai, India)|language=en-US|access-date=2019-08-26}}</ref><ref name=":7">{{Cite web|url=https://www.hindustantimes.com/health/scepticism-shrouds-india-s-tuberculosis-target/story-bcyM89SKSxBhtHXxNL9O2L.html|title=Scepticism shrouds India's tuberculosis target|date=2017-12-11|website=Hindustan Times|language=en|access-date=2019-08-26}}</ref> Approximately 8,000 patients pass through his OPD annually.<ref>{{Cite web|url=https://longitudeprize.org/people/dr-zarir-f-udwadia|title=Dr Zarir F Udwadia {{!}} Longitude Prize|website=longitudeprize.org|access-date=2019-08-26}}</ref><ref>{{Cite web|url=https://everylifecounts.ndtv.com/1-indian-dies-tuberculosis-every-minute-no-one-immune-says-expert-15867|title=1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert|last=Taneja|first=Richa|date=2017-08-01|website=Everylifecounts.NDTV.com|language=en-US|access-date=2019-08-26}}</ref> Udwadia established a Chest Medicine Department at the Hinduja Hospital in 1992, and the city’s first Sleep Laboratory in 1994.<ref name=":6" /> He serves on the editorial board of [[Thorax (journal)|Thorax]], a respiratory medicine journal,<ref>{{Cite web|url=https://thorax.bmj.com/pages/editorial-board/|title=Editorial Board|website=Thorax|language=en|access-date=2019-08-25}}</ref> and has authored over 140 publications.<ref name=":3" />  


== Drug-Resistant tuberculosis ==
== Drug-Resistant tuberculosis ==
Line 11: Line 11:
While the [[World Health Organization|WHO]] eventually said that defining resistance beyond XDR-TB was not recommended,<ref name=":5" /> Udwadia's research drew the attention of the medical community to the growing epidemic of drug-resistant TB.<ref name=":0" /> The coordinator of the WHO's [[Stop TB Partnership|STOP TB]] department called his findings a wake up call.<ref name=":9" /> His research eventually led to improvements in the way TB is managed in India, and elsewhere, and forced the government to make changes to the state-run TB control initiative, or the Revised National Tuberculosis Control Programme.<ref name=":1" /> The government increased the budget for the program, and dispatched rapid GeneXpert machines, which can conduct highly sensitive molecular diagnostic testing.<ref name=":5" />
While the [[World Health Organization|WHO]] eventually said that defining resistance beyond XDR-TB was not recommended,<ref name=":5" /> Udwadia's research drew the attention of the medical community to the growing epidemic of drug-resistant TB.<ref name=":0" /> The coordinator of the WHO's [[Stop TB Partnership|STOP TB]] department called his findings a wake up call.<ref name=":9" /> His research eventually led to improvements in the way TB is managed in India, and elsewhere, and forced the government to make changes to the state-run TB control initiative, or the Revised National Tuberculosis Control Programme.<ref name=":1" /> The government increased the budget for the program, and dispatched rapid GeneXpert machines, which can conduct highly sensitive molecular diagnostic testing.<ref name=":5" />


He continues to be an outspoken critic of the government's failures to address the TB problem,<ref>{{Cite journal|last=Mushtaq|first=Ammara|date=2018-11-01|title=United to end tuberculosis|url=https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30416-8/abstract|journal=The Lancet Respiratory Medicine|language=English|volume=6|issue=11|pages=818–819|doi=10.1016/S2213-2600(18)30416-8|issn=2213-2600|pmid=30297271}}</ref> and a vocal advocate for newer diagnosis and treatment for TB patients.<ref name=":2" /><ref>{{Cite web|url=https://thewire.in/health/multi-drug-resistant-tb-bedaquiline-deaths|title=TB Killed Shreya Tripathi, But Her Death Could Have Been Avoided|website=The Wire|access-date=2019-08-26}}</ref><ref name=":7" /><ref name=":4" />
He continues to be an outspoken critic of the government's failures to address the TB problem,<ref>{{Cite journal|last=Mushtaq|first=Ammara|date=2018-11-01|title=United to end tuberculosis|url=https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30416-8/abstract|journal=The Lancet Respiratory Medicine|language=English|volume=6|issue=11|pages=818–819|doi=10.1016/S2213-2600(18)30416-8|issn=2213-2600|pmid=30297271}}</ref> and a vocal advocate for newer diagnosis and treatment for TB patients.<ref name=":4" /><ref name=":7" /><ref name=":2" /><ref>{{Cite web|url=https://thewire.in/health/multi-drug-resistant-tb-bedaquiline-deaths|title=TB Killed Shreya Tripathi, But Her Death Could Have Been Avoided|website=The Wire|access-date=2019-08-26}}</ref>


==References==
==References==

Revision as of 22:21, 3 January 2022

Zarir Udwadia (born 1960) is an Indian pulmonologist and researcher.[1][2][3] His work on drug resistant tuberculosis has led to improvements in India's National Tuberculosis Control Programme.[1][4] Udwadia was the only Indian invited by the WHO to be part of the TB ‘Guidelines Group’, which formulated the 4th edition of the TB Guidelines, published in 2010.[2][5][6] He was also the only doctor to be named among India's best strategists.[7]

Professional life

Udwadia is a graduate of the Grant Medical College, Mumbai.[6] He spent five years training in the UK at various centres, including Brompton Hospital, London.[4][6] He practices at the P.D. Hinduja National Hospital and Medical Research Centre and the Breach Candy Hospital, in Mumbai.[6][8][9] Approximately 8,000 patients pass through his OPD annually.[10][11] Udwadia established a Chest Medicine Department at the Hinduja Hospital in 1992, and the city’s first Sleep Laboratory in 1994.[6] He serves on the editorial board of Thorax, a respiratory medicine journal,[12] and has authored over 140 publications.[5]

Drug-Resistant tuberculosis

Udwadia runs a free weekly TB clinic at the Hinduja Hospital, which he set up in 1992, on his return to India, after his training in the UK.[13] It is the busiest outpatient clinic at the Hinduja hospital,[13] with patients traveling from many parts of the country, and some lining up overnight, to be seen by him.[1][4]

In December 2011, Udwadia documented twelve cases of what he called totally drug-resistant ('TDR') TB, a strain of the disease that seemed to show resistance to all known treatments.[14][15][16] There were only two other episodes of TDR-TB reported in the world before this- in Iran in 2009, and Italy in 2007.[14][16] Along with his colleagues at the Hinduja Hospital, he published a letter describing four of these cases in the journal Clinical Infectious Diseases.[14] The journal letter prompted extensive media attention. Government officials publicly denied the issue, accused him of wrongly spreading panic, and a Mumbai health official seized patient samples from his laboratory.[13]

While the WHO eventually said that defining resistance beyond XDR-TB was not recommended,[4] Udwadia's research drew the attention of the medical community to the growing epidemic of drug-resistant TB.[1] The coordinator of the WHO's STOP TB department called his findings a wake up call.[16] His research eventually led to improvements in the way TB is managed in India, and elsewhere, and forced the government to make changes to the state-run TB control initiative, or the Revised National Tuberculosis Control Programme.[7] The government increased the budget for the program, and dispatched rapid GeneXpert machines, which can conduct highly sensitive molecular diagnostic testing.[4]

He continues to be an outspoken critic of the government's failures to address the TB problem,[17] and a vocal advocate for newer diagnosis and treatment for TB patients.[3][9][13][18]

References

  1. 1.0 1.1 1.2 1.3 "India's 'tuberculosis warrior'". 2018-03-24. Retrieved 2019-08-25.
  2. 2.0 2.1 Aug 18, Malathy Iyer | TNN | Updated; 2018; Ist, 6:09. "No more jabs, now new pills to treat TB | Mumbai News - Times of India". The Times of India. Retrieved 2019-08-26.{{cite web}}: CS1 maint: numeric names: authors list (link)
  3. 3.0 3.1 Ubaid, Mir. "The challenges of treating drug-resistant TB in India". www.aljazeera.com. Retrieved 2019-08-26.
  4. 4.0 4.1 4.2 4.3 4.4 "TB Online - The right dose, the right chance: India's battle with drug-resistant TB". www.tbonline.info. Retrieved 2019-08-26.
  5. 5.0 5.1 "'The Ticking Time Bomb': A Doctor on Whether TB Can Be Eliminated from India". The Better India. 2019-04-04. Retrieved 2019-08-25.
  6. 6.0 6.1 6.2 6.3 6.4 "Chest Physician in Mumbai - Dr Zarir F. Udwadia | P.D. Hinduja Hospital". www.hindujahospital.com. Retrieved 2019-08-25.
  7. 7.0 7.1 "India's best strategists: 15 dreamers who have translated their insight into reality". The Economic Times. Retrieved 2019-08-25.
  8. "Dr.Zarir Udwadia". TEDxGateway - India's Largest Ideas Platform (Mumbai, India). Retrieved 2019-08-26.
  9. 9.0 9.1 "Scepticism shrouds India's tuberculosis target". Hindustan Times. 2017-12-11. Retrieved 2019-08-26.
  10. "Dr Zarir F Udwadia | Longitude Prize". longitudeprize.org. Retrieved 2019-08-26.
  11. Taneja, Richa (2017-08-01). "1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert". Everylifecounts.NDTV.com. Retrieved 2019-08-26.
  12. "Editorial Board". Thorax. Retrieved 2019-08-25.
  13. 13.0 13.1 13.2 13.3 Anand, Geeta (2016-09-02). "Battling Drug-Resistant TB, and the Indian Government". The New York Times. ISSN 0362-4331. Retrieved 2019-08-25.
  14. 14.0 14.1 14.2 Loewenberg, Samuel (2012-01-21). "India reports cases of totally drug-resistant tuberculosis". The Lancet. 379 (9812): 205. doi:10.1016/S0140-6736(12)60085-3. ISSN 0140-6736. PMID 22272391.
  15. "TB Online - India: WHO's shorter treatment for multidrug-resistant TB, city may not gain". www.tbonline.info. Retrieved 2019-08-26.
  16. 16.0 16.1 16.2 "Totally drug-resistant TB at large in India". www.newscientist.com. Retrieved 2019-08-26.
  17. Mushtaq, Ammara (2018-11-01). "United to end tuberculosis". The Lancet Respiratory Medicine. 6 (11): 818–819. doi:10.1016/S2213-2600(18)30416-8. ISSN 2213-2600. PMID 30297271.
  18. "TB Killed Shreya Tripathi, But Her Death Could Have Been Avoided". The Wire. Retrieved 2019-08-26.